Antibiotics
Step 3 usually tests syndrome-based empiric therapy and escalation/de-escalation logic.
| Syndrome | Typical Empiric Coverage | Notes |
|---|---|---|
| Community-acquired pneumonia outpatient | Amoxicillin, doxycycline, or macrolide depending risk/local resistance | Add broader coverage if comorbidities. |
| CAP inpatient non-ICU | Beta-lactam + macrolide or respiratory fluoroquinolone | Assess severity and QT risks. |
| Severe pneumonia | Beta-lactam + macrolide/fluoroquinolone; add MRSA/Pseudomonas coverage if risk | Culture before antibiotics if no delay. |
| UTI uncomplicated | Nitrofurantoin, TMP-SMX, fosfomycin | Check pregnancy/renal function. |
| Pyelonephritis | Ceftriaxone initially or fluoroquinolone if appropriate | Admit if septic, pregnant, vomiting, obstructed. |
| Cellulitis nonpurulent | Strep coverage such as cephalexin | Add MRSA coverage if purulent/risk factors. |
| Meningitis adult | Vancomycin + ceftriaxone; add ampicillin if older/immunocompromised/pregnant | Do not delay antibiotics for LP if CT needed first. |
| Intra-abdominal infection | Gram-negative + anaerobe coverage | Source control matters. |
| Neutropenic fever | Anti-pseudomonal beta-lactam | Medical emergency. |
Classic Organism Associations
- Animal bite: Pasteurella → amoxicillin-clavulanate.
- Diabetic foot: polymicrobial; cover gram-positive, gram-negative, anaerobes depending severity.
- C. difficile: oral vancomycin or fidaxomicin for typical initial disease.
- MRSA skin abscess: incision and drainage; add antibiotics when systemic signs/risk factors.